Oncolytics Biotech  logo
Oncolytics Biotech ONCY
$ 0.99 -1.22%

Annual report 2023
added 11-09-2024

report update icon

Oncolytics Biotech Financial Statements 2011-2024 | ONCY

Annual Financial Statements Oncolytics Biotech

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- - 74.4 M 52.7 M 105 M 29 M 75.5 M 24 M 30.4 M 36.9 M 138 M 274 M 327 M

Shares

- - 53.5 M 22.1 M 22.1 M 16 M 13.9 M 12.6 M 11.9 M 9.25 M 8.79 M 8.01 M 7.46 M

Historical Prices

1 2.14 1.39 2.38 4.76 1.81 5.42 2 2.56 5.04 14.7 37.2 37

Net Income

- - -26.3 M -22.5 M -33.1 M -17 M -15.6 M -15.1 M -13.7 M -18.6 M -23.5 M -36.4 M -29 M

Revenue

- - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -5.33 M

Operating Income

- - -26.2 M -25.5 M -20.4 M -17.3 M -15.6 M -15.3 M -13.9 M - - - -

Interest Expense

- - - - - - - - - - - - -

EBITDA

- - -26.2 M -25.5 M -20.4 M -17.3 M -15.6 M -15.1 M -13.7 M -18.7 M -23.8 M -36.6 M -28.5 M

Operating Expenses

- 11.5 M 13.3 M 12.5 M 9.56 M 7.24 M 6.21 M 15.3 M 13.9 M 18.8 M 23.9 M 36.7 M 23.2 M

General and Administrative Expenses

- - - - - - - 5.36 M 5.14 M - 373 K 731 K 1.14 M

All numbers in CAD currency

Quarterly Income Statement Oncolytics Biotech

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in CAD currency